Clinical trials: SANS

Obesity, Type 2 Diabetes

EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects

• Terminated
• Age: 21 to 65 years
• Medical device

This study will evaluate the safety and efficacy of the EndoBarrier® SANS™ in overweight and obese subjects with type 2 diabetes.

Trial name

NCT02443753

Testing

EndoBarrier SANS

Where

Malaysia

Volunteers

7 people, healthy volunteers welcome

Sponsor

Morphic Medical Inc.